The Andhra Sugars Limited (ANDHRSUGAR.NS)
INR 95.87
(-1.04%)
INR 95.87
(-1.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.34 Billion | 2.85 Billion | 1.75 Billion | 2.52 Billion | 1.81 Billion | 1.18 Billion |
| Net Income | 751.04 Million | 2.45 Billion | 2.22 Billion | 1.44 Billion | 2.26 Billion | 2.54 Billion |
| Depreciation & Amortization | 756.5 Million | 670.99 Million | 639.62 Million | 612.41 Million | 624.1 Million | 554.49 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 141.42 Million | 408.71 Million | -493.37 Million | 589.84 Million | -406.58 Million | -1.4 Billion |
| Other non-cash items | 887.8 Million | -679.01 Million | -616.25 Million | -117.56 Million | -668.15 Million | -504.27 Million |
| Investing Cash Flow | -1.17 Billion | -2.04 Billion | -256.87 Million | -1.41 Billion | -153.57 Million | -1.38 Billion |
| Investments in PPE | -1.34 Billion | -2.16 Billion | -931.32 Million | -902.05 Million | -515.15 Million | -651.63 Million |
| Acquisitions | 5.81 Million | -6.58 Million | -476.86 Million | 543.29 Million | -151.99 Million | 95.12 Million |
| Investment purchases | -3.86 Billion | -4.82 Billion | -2.36 Billion | -3.22 Billion | -5.38 Billion | -4.82 Billion |
| Sales/Maturities of investments | 4.02 Billion | 4.83 Billion | 2.85 Billion | 2.67 Billion | 5.53 Billion | 4.05 Billion |
| Other Investing Activities | 332.07 Million | 124.07 Million | 659.79 Million | -510.62 Million | 361.58 Million | -53.66 Million |
| Financing Cash Flow | -212.9 Million | -914.19 Million | -1.49 Billion | -1.32 Billion | -1.67 Billion | 232.13 Million |
| Debt repayment | -72.5 Million | -313.32 Million | -1.04 Billion | -1.02 Billion | -410.92 Million | -883.21 Million |
| Dividends payments | -280.61 Million | -550.77 Million | -281.78 Million | -26.64 Million | -990.07 Million | -292.48 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14.22 Million | -50.09 Million | -152.95 Million | -265.15 Million | -437.33 Million | 1.4 Billion |
| Accounts receivables | 435.89 Million | 93.66 Million | -271.64 Million | -48.31 Million | -181.93 Million | -80.77 Million |
| Accounts payables | 87.84 Million | -41.24 Million | 200.08 Million | 224.51 Million | 103.97 Million | -12.14 Million |
| Inventory | -200.92 Million | 536.51 Million | -437.25 Million | 186.17 Million | -140.24 Million | -1.48 Billion |
| Other working capital | -181.37 Million | -180.21 Million | 15.44 Million | 227.46 Million | -188.38 Million | 169.73 Million |
| Cash at beginning of period | 113.03 Million | 182.07 Million | 165.79 Million | 375.04 Million | 388.46 Million | 351.95 Million |
| Cash at end of period | 555.71 Million | 81.78 Million | 169.57 Million | 165.79 Million | 375 Million | 388.46 Million |
| Capital Expenditure | -1.34 Billion | -2.16 Billion | -931.32 Million | -902.05 Million | -515.15 Million | -651.63 Million |
| Effect of forex changes on cash | - | - | 12.5 Million | 2000.00 | 47 Thousand | 1000.00 |
| Net cash flow / Change in cash | 442.68 Million | -100.29 Million | 3.78 Million | -209.25 Million | -13.46 Million | 36.5 Million |
| Free Cash Flow | -912 Thousand | 689.82 Million | 820.81 Million | 1.62 Billion | 1.29 Billion | 537.16 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 148.02 Million | 751.04 Million | 253.03 Million | 100.5 Million | 186.91 Million | 210.59 Million |
| Depreciation & Amortization | - | 756.5 Million | - | 191.05 Million | 185.95 Million | 182.88 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 141.42 Million | - | - | - | - |
| Other non-cash items | -148.02 Million | 887.8 Million | -253.03 Million | -100.5 Million | -186.91 Million | -210.59 Million |
| Investing Cash Flow | - | -1.17 Billion | - | - | - | - |
| Investments in PPE | - | -1.34 Billion | - | - | - | - |
| Acquisitions | - | 5.81 Million | - | - | - | - |
| Investment purchases | - | -3.86 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 4.02 Billion | - | - | - | - |
| Other Investing Activities | - | 332.07 Million | - | - | - | - |
| Financing Cash Flow | - | -212.9 Million | - | - | - | - |
| Debt repayment | - | -72.5 Million | - | - | - | - |
| Dividends payments | - | -280.61 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -14.22 Million | - | - | - | - |
| Accounts receivables | - | 435.89 Million | - | - | - | - |
| Accounts payables | - | 87.84 Million | - | - | - | - |
| Inventory | - | -200.92 Million | - | - | - | - |
| Other working capital | - | -181.37 Million | - | - | - | - |
| Cash at beginning of period | - | 113.03 Million | - | 498.17 Million | 126.26 Million | 113.03 Million |
| Cash at end of period | - | 555.71 Million | - | 880.29 Million | 498.17 Million | 478.79 Million |
| Capital Expenditure | - | -1.34 Billion | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 442.68 Million | - | 382.11 Million | 371.91 Million | 365.76 Million |
| Free Cash Flow | - | -912 Thousand | - | 382.11 Million | 371.91 Million | 365.76 Million |
POROF
COGZF
GRASIM
INSECTICID
MEHIF
LSI